← FDA Drug Approvals (Drugs@FDA)

ACTEMRA

BLA · Biologics License Application · Sponsor: GENENTECH · Approved 2013-10-21

Drug application

FDA Application #

BLA125472

Application type

Biologics License Application

Brand name

ACTEMRA

Generic name

TOCILIZUMAB

Active ingredients

TOCILIZUMAB

Dosage form

INJECTABLE

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

GENENTECH

Manufacturer

Genentech, Inc.

First approval

2013-10-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown